MRI signs of CNS demyelinating diseases

被引:9
|
作者
Etemadifar, Masoud [1 ]
Ashourizadeh, Helia [2 ]
Nouri, Hosein [3 ,4 ]
Kargaran, Parisa K. [5 ]
Salari, Mehri [6 ]
Rayani, Milad [3 ]
Aghababaee, Ali [3 ]
Abhari, Amir Parsa [3 ,4 ]
机构
[1] Isfahan Univ Med Sci, Dept Neurosurg, Esfahan, Iran
[2] Shahid Beheshti Univ Med Sci, Funct Neurosurg Res Ctr, Shohada Tajrish Neurosurg Ctr Excellence, Tehran, Iran
[3] Isfahan Univ Med Sci, Alzahra Res Inst, Esfahan, Iran
[4] Universal Sci Educ & Res Network USERN, Network Immun Infect Malignancy & Autoimmun NIIMA, Esfahan, Iran
[5] Mayo Clin, Ctr Regenerat Med, Dept Cardiovasc Med, Rochester, MN USA
[6] Shahid Beheshti Univ Med Sci, Dept Neurol Dis, Tehran, Iran
关键词
Magnetic Resonance Imaging; Demyelinating diseases; Multiple Sclerosis; Neuromyelitis Optica Spectrum Disorder;
D O I
10.1016/j.msard.2020.102665
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The differential diagnosis of the central nervous system (CNS) demyelinating diseases can be greatly facilitated by visualization and appreciation of pathognomonic radiological signs, visualized on magnetic resonance imaging (MRI) sequences. Given the distinct therapeutic approaches for each of these diseases, a decisive and reliable diagnosis in patients presenting with demyelination-associated symptoms is of crucial value. Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) are major examples of such conditions, each possessing a number of MRI signs, closely associated with the disorder. This pictorial review aims to describe seventeen pathognomonic MRI signs associated with several CNS demyelinating disorders including MS, NMOSD, myelin oligodendrocyte glycopmtein-associated disease, BalO's concentric sclerosis, metachromatic leukodystrophy, progressive multifocal leukoencephalopathy, and neurosarcoidosis.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] COVID-19 and the risk of CNS demyelinating diseases: A systematic review
    Lotan, Itay
    Nishiyama, Shuhei
    Manzano, Giovanna S.
    Lydston, Melissa
    Levy, Michael
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [32] QKI-V5 is downregulated in CNS inflammatory demyelinating diseases
    Lavon, Iris
    Leykin, Ina
    Charbit, Hanna
    Binyamin, Orli
    Brill, Livnat
    Ovadia, Haim
    Vaknin-Dembinsky, Adi
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 39
  • [33] Heterogeneity of the mechanisms of nerve cell damage in demyelinating autoimmune diseases of the CNS
    Abdurasulova I.N.
    Klimenko V.M.
    Neuroscience and Behavioral Physiology, 2011, 41 (4) : 364 - 374
  • [34] Validation of a symptom-based questionnaire for pediatric CNS demyelinating diseases
    Waldman, Amy T.
    Yeshokumar, Anusha K.
    Lavery, Amy
    Liu, Geraldine
    Pineles, Stacy L.
    Repka, Michael X.
    Adang, Laura
    Narula, Sona
    Liu, Grant T.
    JOURNAL OF AAPOS, 2019, 23 (03): : 157 - 158
  • [35] Phosphorylated neurofilament heavy subunits as a marker of neurodegeneration in demyelinating diseases of the CNS
    A. A. Vorobyeva
    V. V. Fominykh
    M. V. Onufriev
    M. N. Zakharova
    N. V. Gulyaeva
    Neurochemical Journal, 2014, 8 : 221 - 225
  • [36] Non-infectious meningitis and CNS demyelinating diseases: A conceptual review
    Etemadifar, M.
    Fereidan-Esfahani, M.
    Sedaghat, N.
    Kargaran, P. K.
    Mansouri, A. R.
    Abhari, A. P.
    Aghababaei, A.
    Jannesari, A.
    Salari, M.
    Ganjalikhani-Hakemi, M.
    Nouri, H.
    REVUE NEUROLOGIQUE, 2023, 179 (06) : 533 - 547
  • [37] Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases
    Di Pauli, Franziska
    Mader, Simone
    Rostasy, Kevin
    Schanda, Kathrin
    Bajer-Kornek, Barbara
    Ehling, Rainer
    Deisenhammer, Florian
    Reindl, Markus
    Berger, Thomas
    CLINICAL IMMUNOLOGY, 2011, 138 (03) : 247 - 254
  • [38] Phosphorylated neurofilament heavy subunits as a marker of neurodegeneration in demyelinating diseases of the CNS
    Vorobyeva, A. A.
    Fominykh, V. V.
    Onufriev, M. V.
    Zakharova, M. N.
    Gulyaeva, N. V.
    NEUROCHEMICAL JOURNAL, 2014, 8 (03) : 221 - 225
  • [39] On how altered glutamate homeostasis may contribute to demyelinating diseases of the CNS
    Matute, C
    Domercq, M
    Fogarty, DJ
    de Zulueta, MP
    Sánchez-Gómez, MV
    THE FUNCTIONAL ROLES OF GLIAL CELLS IN HEALTH AND DISEASE: DIALOGUE BETWEEN GLIA AND NEURONS, 1999, 468 : 97 - 107
  • [40] Development and validation of a simple and practical tool for differentiating MS from other idiopathic inflammatory demyelinating diseases of CNS with brain MRI
    Patel, J.
    Pires, A.
    Derman, A.
    Fatterpekar, G.
    Charlson, E.
    Oh, C.
    Kister, I.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 459 - 460